INHIBITION OF VOLTAGE-GATED CA2-CELL LUNG-CARCINOMA BY THE CA2+( CHANNEL ACTIVITY IN SMALL)CALMODULIN-DEPENDENT PROTEIN-KINASE INHIBITOR KN-62 SULFONYL)-N-METHYL-L-TYROSYL]-4-PHENYLPIPERAZINE)/
Cl. Williams et al., INHIBITION OF VOLTAGE-GATED CA2-CELL LUNG-CARCINOMA BY THE CA2+( CHANNEL ACTIVITY IN SMALL)CALMODULIN-DEPENDENT PROTEIN-KINASE INHIBITOR KN-62 SULFONYL)-N-METHYL-L-TYROSYL]-4-PHENYLPIPERAZINE)/, Biochemical pharmacology, 50(12), 1995, pp. 1979-1985
Although small cell lung carcinoma (SCLC) cells express both voltage-g
ated Ca2+ channels (VGCC) and second messenger-operated Ca2+ channels
(SMOCC), little is known about the factors that regulate the activity
of these channels in SCLC cells. Ca2+/calmodulin-dependent protein kin
ase (CaM kinase) type II has been implicated recently in regulating Ca
2+ channel activity in other cell types. Because of this, we investiga
ted the effects of the specific CaM kinase antagonist nesulfonyl)-N-me
thyl-L-tryosyl]-4-phenylpiperazine (KN-62) on Ca2+ channel activity in
SCLC cells. Incubation with 10 mu M KN-62 for 20 min inhibited depola
rization-dependent Ca-45(2+) influx by 96.1 +/- 2.1% in four independe
nt SCLC cell lines, and by 42.2 +/- 6.8% in the NCI-H146 SCLC cell lin
e. Similar inhibitory effects of KN-62 were observed when Fura-2 was u
sed to measure depolarization-dependent Ca2+ influx. These results ind
icate that KN-62 potently inhibits VGCC activity in SCLC cells. In con
trast, KN-62 (10 mu M, 20 min) did not inhibit significantly Ca2+ mobi
lization induced by muscarinic acetylcholine receptor (mAChR) activati
on in SCLC cells. This indicates that SMOCC are less susceptible than
VGCC to inhibition by KN-62 in SCLC cells. Because mAChR activation al
so inhibits VGCC activity in SCLC cells, we examined the effects of KN
-62 on the mAChR-mediated inhibition of VGCC activity. To do this, we
measured depolarization-dependent Ca-45(2+) influx in SCLC cells incub
ated with submaximal concentrations of KN-62 and the mAChR agonist car
bachol. Treatment of cells with both drugs resulted in almost twice as
much inhibition of VGCC activity as in cells treated with only one of
the drugs. This indicates that inactivation of CaM kinase with KN-62
does not suppress the ability of mAChR agonists to inhibit VGCC activi
ty.